Focus Stocks
Sector Round Up - Pharmaceuticals Rise: SNY, TEVA, KG
Published on Wednesday, 08 September 2010 13:13 Written by Christian Paolinetti
New York, September 8th (TradersHuddle.com) - At the half of the trading session tha market is trading higher with the S&P 500 adding 0.88%. Stocks of Pharmaceutical Companies are also trading higher, with NYSE Drug index at 295.46, which represents 0.92% versus the previous tradings session close.
The Drug index is having a broad rally with 15 out of 15 components trading higher.
So far the sector's top performer today is Sanofi-Aventis (NYSE:SNY) currently trading at $30.38 representing 2.17%. versus the previous trading session price action. Sanofi-Aventis , the Paris, France based global pharmaceutical company, shares have defined support at $28.03 and resistance at $30.21.
Teva (NASDAQ:TEVA) is also among the top performers, currently trading at $54.19 representing 2.01% from its previous close. Teva, the largest generic drug maker in the world has calculated support and resistance levels at $46.99 and $50.78 respectively. The other top performer is King Pharmaceuticals (NYSE:KG), which is trading at $9.19 representing 1.43% from the previous trading session.
The sector's worst performer at the mid point of the trading session is Forest Laboratories (NYSE:FRX) that is trading at $29.49 or 0.14% from the previous close. Forest Laboratories, the maker of branded and generic forms of ethical drug products shares have defined support at $26.92 and resistance at $28.78. Also among the worst performers is Abbott Labs (NYSE:ABT), which is trading at $50.68 representing 0.38% from the previous trading session.
Related Articles
- Four-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Continued Improvement Across All Endpoints
- Abbott Creates New Similac SimplySmart™ Baby Bottle with Innovative Features
- Sanofi-Aventis Close to Resistance
- Sanofi: 2011 Results Benefit from Genzyme Acquisition
- Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
- Sanofi CEO Chris Viehbacher Comments on 2011 Results
- Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex
- Sanofi Announces FDA Approval of Sklice® Lotion for the Treatment of Head Lice
- Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
- Trading Idea - Momentum Building in Sanofi-Aventis
Related Partner Headlines
- Sanofi Announces FDA Approval of Sklice® Lotion for the Treatment of Head Lice - Benzinga
- UPDATE: Morgan Stanley Downgrades Teva Pharmaceuticals to Equal-Weight - Benzinga
- Morgan Stanley Downgrades Teva Pharmaceutical to Equal-weight - Benzinga
- Teva Gets Upgrade on Revenue Growth - TheStreet.com
- Teva Pharmaceutical Industries Ltd Stock Upgraded (TEVA) - TheStreet.com
- Teva Taps Bristol-Myers' Levin as Next CEO - TheStreet.com
- Analysts' Actions: GOOG, FRX, JBHT, KSU - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Winner - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Wunderlich Securities Downgrades A123 SYSTEMS from Hold to Sell, Lowers PT from to {loadposition aroundstreet}.5 - Benzinga -
EarlyBirdCapital Downgrades iRobotoration from Buy to Hold - Benzinga -
Capital One to Test Fed's 'Too Big To Fail' Cred - TheStreet.com -
Morgan Stanley Upgrades CIT Group from Equal-weight to Overweight, Raises PT from to - Benzinga -
Jefferies & Company Downgrades Solutia from Buy to Hold, Lowers PT from to .5 - Benzinga -
Rolls-Royce Posts Rise In 2011 Profit, Lifts Dividend By 9% - Benzinga -
Jefferies & Company Downgrades DuPont Fabros Technology from Buy to Hold, Lowers PT from to - Benzinga -
JP Morgan Downgrades iRobotoration from Neutral to Underweight, Lowers PT from .5 to - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
Manulife Financial Corporation declares dividends -
Manulife Financial ends 2011 with net income of $129 million, an improvement of $1.8 billion over 2010, achieves its three-year product repositioning and continues to pursue sustainable growth -
Dunkin' Brands Reports Fourth Quarter and Full Year 2011 Results -
Ur-Energy Completes Third Uranium Sales Agreement -
Qualifying State Residents Can Get Help With Heating Bills -
Lufkin Industries Reports Strong Fourth Quarter and Full Year 2011 Earnings from Continuing Operations -
Clear Channel’s Worldwide Multi-Platform Promotion of Madonna’s New Single “Give Me All Your Luvin’” Helps Propel MDNA Album to No. 1 on iTunes, Drives Record-Breaking Sales -
COPT Reports 2011 Results; Affirms 2012 Guidance










